REFRACTORY DIFFERENTIATED THYROID GLAND CARCINOMA

Clinical trials for REFRACTORY DIFFERENTIATED THYROID GLAND CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new REFRACTORY DIFFERENTIATED THYROID GLAND CARCINOMA trials appear

Sign up with your email to follow new studies for REFRACTORY DIFFERENTIATED THYROID GLAND CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 2

Head-to-Head trial seeks best drug combo for tough thyroid cancer

Disease control Recruiting now

This study aims to find out which of two drug treatments works better for people with an advanced form of thyroid cancer that has a specific genetic change (BRAF V600E) and has stopped responding to standard therapies. Researchers will compare a two-drug combination (dabrafenib a…

Matched conditions: REFRACTORY DIFFERENTIATED THYROID GLAND CARCINOMA

Phase: PHASE3 • Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Disease control

Last updated Apr 01, 2026 14:42 UTC

REFRACTORY DIFFERENTIATED THYROID GLAND CARCINOMA

Get alerted when new REFRACTORY DIFFERENTIATED THYROID GLAND CARCINOMA trials appear

Head-to-Head trial seeks best drug combo for tough thyroid cancer